Drug Shortage Report for OXALIPLATIN INJECTION
Report ID | 2606 |
Drug Identification Number | 02436957 |
Brand name | OXALIPLATIN INJECTION |
Common or Proper name | OXALIPLATIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | OXALIPLATIN |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 40mL fiole/vial |
ATC code | L01XA |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-01-20 |
Estimated end date | 2017-04-17 |
Actual end date | 2017-04-11 |
Shortage status | Resolved |
Updated date | 2017-04-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2017-04-12 | English | Compare |
v6 | 2017-04-11 | French | Compare |
v5 | 2017-04-11 | English | Compare |
v4 | 2017-04-04 | French | Compare |
v3 | 2017-04-04 | English | Compare |
v2 | 2017-03-14 | French | Compare |
v1 | 2017-03-14 | English | Compare |
Showing 1 to 7 of 7